title: Evaluation of sericin as a fetal bovine serum-replacing cryoprotectant during freezing of human mesenchymal stromal cells and human osteoblast-like cells.
abstract: A reliable, cryoprotective, xeno-free medium suitable for different cell types is highly desirable in regenerative medicine. There is danger of infection or allergic reaction with the use of fetal bovine serum (FBS), making it problematic for medical applications. The aim of the present study was to develop an FBS-free cryoprotective medium for human mesenchymal stromal cells (hMSCs; primary cells) and immortalized human osteoblasts (SAOS-2 cell line). Furthermore, we endeavored to eliminate or reduce the presence of dimethyl sulfoxide (DMSO) in the medium. Sericin, a sticky protein derived from the silkworm cocoon, was investigated as a substitute for FBS and DMSO in the freezing medium. Cell viability (24 hours after thawing, both hMSC and SAOS-2) and colony-forming ability (2 weeks after thawing, only for hMSCs) were both determined. The FBS-free medium with 1% sericin in 10% DMSO was found to be a suitable freezing medium for primary hMSCs, in contrast to immortalized human osteoblasts. Surprisingly, the storage of hMSCs in a cultivation medium with only 10% DMSO also provided satisfactory results. Any drop in DMSO concentration led to significantly worse survival of cells, with little improvement in hMSC survival in the presence of sericin. Thus, sericin may substitute for FBS in the freezing medium for primary hMSCs, but cannot substitute for DMSO.
authors.affiliation: 1 Institute of Inherited Metabolic Disorders, Faculty of Science, Charles University in Prague , Prague, Czech Republic .
authors.forename: Martina
authors.initials: M
authors.lastname: Verdanova
authors.forename: Robert
authors.initials: R
authors.lastname: Pytlik
authors.forename: Marie Hubalek
authors.initials: MH
authors.lastname: Kalbacova
mesh_terms: D000818:Animals; D002417:Cattle; D002470:Cell Survival / Q000187:drug effects; D015925:Cryopreservation / Q000379:methods*; D003451:Cryoprotective Agents / Q000737:chemistry* / Q000494:pharmacology; D016895:Culture Media, Serum-Free / Q000737:chemistry / Q000494:pharmacology; D004121:Dimethyl Sulfoxide / Q000737:chemistry / Q000494:pharmacology; D005615:Freezing; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D010006:Osteoblasts / Q000166:cytology*; D047030:Sericins / Q000737:chemistry* / Q000494:pharmacology; D044967:Serum / Q000737:chemistry
chemical_list: D003451:Cryoprotective Agents; D016895:Culture Media, Serum-Free; D047030:Sericins; D004121:Dimethyl Sulfoxide
references.citation: Stem Cell Rev Rep. 2013 Feb;9(1):16-31
references.pmid: 22628114
references.citation: Biotechnol Appl Biochem. 2005 Oct;42(Pt 2):183-8
references.pmid: 15943583
references.citation: Int J Mol Sci. 2009 Mar 31;10(4):1514-24
references.pmid: 19468322
references.citation: Waste Manag Res. 2012 Mar;30(3):217-24
references.pmid: 21558082
references.citation: Oncol Rep. 2000 Sep-Oct;7(5):1049-52
references.pmid: 10948337
references.citation: Biol Res. 2012;45(3):269-77
references.pmid: 23283436
references.citation: Hear Res. 2008 Feb;236(1-2):52-60
references.pmid: 18207679
references.citation: Cryobiology. 2007 Aug;55(1):60-5
references.pmid: 17618999
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7841-5
references.pmid: 11427725
references.citation: J Dent Res. 2002 Aug;81(8):531-5
references.pmid: 12147742
references.citation: Biomaterials. 2009 Jul;30(20):3415-27
references.pmid: 19362364
references.citation: Organogenesis. 2009 Jul;5(3):90-6
references.pmid: 20046670
references.citation: J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):354-60
references.pmid: 21678022
references.citation: Nature. 2002 Jul 4;418(6893):41-9
references.pmid: 12077603
references.citation: Tissue Eng Part A. 2011 Nov;17(21-22):2651-61
references.pmid: 21679124
references.citation: Cancer Res. 1987 Sep 15;47(18):4961-6
references.pmid: 3040234
references.citation: Stem Cells Int. 2012;2012:646038
references.pmid: 22754578
references.citation: Clin Cases Miner Bone Metab. 2012 Jan;9(1):24-7
references.pmid: 22783331
references.citation: Ageing Res Rev. 2011 Jan;10(1):93-103
references.pmid: 20727988
references.citation: Mol Biol Cell. 2002 Dec;13(12):4279-95
references.pmid: 12475952
references.citation: Br J Haematol. 2013 Nov;163(4):501-9
references.pmid: 23992039
references.citation: Science. 1999 Apr 2;284(5411):143-7
references.pmid: 10102814
references.citation: Cryobiology. 2002 Oct;45(2):97-108
references.pmid: 12482375
references.citation: Blood. 2004 Mar 1;103(5):1669-75
references.pmid: 14576065
references.citation: Acta Medica (Hradec Kralove). 2006;49(1):27-33
references.pmid: 16696440
references.citation: Cells Tissues Organs. 2011;193(4):264-73
references.pmid: 21123998
references.citation: Haematologica. 2007 Sep;92(9):1208-15
references.pmid: 17666368
references.citation: Oncol Rep. 2003 May-Jun;10(3):537-43
references.pmid: 12684620
references.citation: Int J Mol Sci. 2010 May 20;11(5):2200-11
references.pmid: 20559510
references.citation: Cell Transplant. 2012;21(2-3):617-22
references.pmid: 22793071